49 EUR
0.2
0.41%
Last update Dec 15, 8:00 AM CET
Market closed
Day range
49
49
Previous close
49.20000
Open
49
Access this stock data via API
Subscribe
Crispr Therapeutics AG
49.00
0.20
0.41%

Statistics

Valuation metrics
Market cap
0
Enterprise value
-63.51M
Trailing P/E (ttm)
-11.29
Forward P/E
PEG ratio
-0.71
Price/Sales (ttm)
0
Price/Book (mrq)
2.34
Enterprise Value/Revenue
-2.13
Enterprise Value/EBITDA
0.17
Overview
Shares outstanding
93.87M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
64
Average volume (90 days)
49
Price summary
52-Week low
30
52-Week high
123.80
52-Week change
-152.65 -508.8%
Beta
50-Day moving average
52.35
200-Day moving average
61.68
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
-215%
Operating margin
-1,333.05%
Operational effectiveness
Return on assets
-16.34%
Return on equity
-18.96%
Income statement
Revenue (ttm)
29.81M
Revenue per share (ttm)
0.41
Quarterly revenue growth (yoy)
Gross profit (ttm)
-64.09M
EBITDA
0
Net income to common (ttm)
-311.96M
Diluted EPS (ttm)
-4.34
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
179.74M
Total Debt/Equity (mrq)
0.11
Current ratio (mrq)
1,621.67%
Book value per share (mrq)
20.98
Cash flow
Cash flow statement
-102.87M
Levered free cash flow (LFCF)
-311.96M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 1 hour 19 minutes

06:40
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).